An injection can be done at any time of day, depending on what works best for the patient
10.1016/j.gie.2024.01.012 30
Bruskewitz R, Girman CJ, Fowler J, Rigby OF, Sullivan M, Bracken RB, et al
A realistic UK timeline One UK-focused source states that the earliest realistic MHRA approval is late 2027 to mid-2028, with NHS access from 2029 at the earliest (Second Nature's UK guide to buying retatrutide online)
Additionally, the FDA has received reports of adverse events, some requiring hospitalization, which were linked to dosing errors and the use of compounded products at doses exceeding those in FDA-approved labeling
Venegas-Borsellino C et al (2021) Impact of COVID-19 on the Intestinal Microbiome